The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

Introduction to Personalized Medicine Part 2

Download it: MP3 | AAC | OGG | OPUS
  • Personalized medicine challenges
  • Developing personalized strategies
  • Traditional study design limitations
  • Crossover trials and their uniqueness
  • Phase three study design inadequacy
  • Generalizability issues
  • Data collection and design for individual patient benefit
  • Observational data and randomized trials
  • Leveraging existing data sources
  • Importance of standardization
  • Integrating multiple studies and data types
  • Future of personalized medicine in various indications

If you found this episode enlightening, we encourage you to share it with friends, colleagues, and anyone who stands to benefit from a deeper understanding of personalized medicine's potential and pitfalls.

Together, we can advance the conversation and move closer to a future where healthcare is as unique as the individuals it serves.

Interested in harnessing the power of leadership to drive meaningful impact in the realm of statistics together? Check out this program: The Effective Statistician with Leadership Program


Comments


New comment

By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.

About this podcast

The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your leadership skills, learn about ongoing discussions in the scientific community, build you knowledge about the health sector and be more efficient at work. This podcast helps statisticians at all levels with and without management experience. It is targeted towards the health, but lots of topics will be important for the wider data scientists community.

by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry

Subscribe

Follow us